Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.07 from other evidence | 0.00 |
| cell type Human Protein Atlas | expressed broadly, no clear home in brain cells | 0.40 |
| chemistry Open Targets | a small-molecule pocket | 0.60 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 40 Parkinson's papers of 4,904 | 0.51 |
| pathways Reactome | 8 pathways; mostly mitochondrial quality control | 1.00 |
No case: the score is under the bar. Receipt 4056
Sealed predictions
- GSDMD in dopamine neurons, braak-0.68 (p 0.042) → -0.58 (p 0.102)receipt 4064
Swarm cases
receipt 4064: GSDMD in dopamine neurons, braak
- power
- full sample -0.61 (p 0.0077, n 18), 95% CI -0.84 to -0.19. the interval excludes zero: something may be there, smaller than a half can see.
- confounder
- adjusted for sex: -0.64 (p 0.0040, n 18). holds up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.69 (p 0.0015, n 18). not the mix.
- skeptic
- leave-one-out range -0.68 to -0.56, sign flips 0; without severely affected donors -0.61 (p 0.0077, n 18). robust.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for GSDMD in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts